中文|English
Sign Up
Shopping cart
Search

The CDE issued a notice to solicit public opinion on the 《Initiation principles and procedures management rules of drug registration inspection (trail)》(Draft for public review)

Column：Industry News Time：2020-04-30
2020-04-30，The CDE issued a notice to solicit public opinion on the 《Initiation principles and procedures management rules of drug registration inspection (trail)》(Draft for public review)

为落实《药品注册管理办法》（国家市场监督管理总局令第27号）药品注册核查与检验启动工作相关要求，规范审评过程中启动注册核查检验工作程序，药品审评中心起草了配套文件《药品注册核查检验启动原则和程序管理规定（试行）》（征求意见稿），2020年04月30日开始，CDE公开征求意见，征求意见时限为2020年4月30日至5月30日。

 

网址链接：http://www.cde.org.cn/news.do?method=viewInfoCommon&id=315049


Previous： The CDE issued a notice to solicit public opinion on the 《Guideline on the Submission of Clinical Trial Data》
Next： The CDE issued a notice to solicit public opinion on the 《Clinical technical requirements for unlisted drugs in China 》